Literature DB >> 10498628

TECK, an efficacious chemoattractant for human thymocytes, uses GPR-9-6/CCR9 as a specific receptor.

B S Youn1, C H Kim, F O Smith, H E Broxmeyer.   

Abstract

Chemokines regulate leukocytes trafficking in normal and inflammation conditions. Thymus-seeding progenitors are made in bone marrow and migrate to the thymus where they undergo their maturation to antigen-specific T cells. Immature T cells are in thymic cortex, while mature thymocytes are in medulla. Chemokines may be important for homing of thymus-seeding progenitors, and/or differential thymocyte localization in thymus. Here we report that GPR-9-6, now called CC chemokine receptor 9 (CCR9), is a receptor for thymus-expressed chemokine, TECK. Among a panel of chemokines tested, TECK specifically induced calcium flux in CCR9-expressing cell lines. We also showed that TECK efficaciously induced chemotaxis of immature CD4(+)CD8(+) double-positive, and mature CD4(+) and CD8(+) single-positive human thymocytes. Our data suggest that TECK/CCR9 interaction may play a pivotal role in T-cell migration in the thymus.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10498628

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  18 in total

1.  Toward rigorous comprehension of biological complexity: modeling, execution, and visualization of thymic T-cell maturation.

Authors:  Sol Efroni; David Harel; Irun R Cohen
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

2.  Low thymic output in the 22q11.2 deletion syndrome measured by CCR9+CD45RA+ T cell counts and T cell receptor rearrangement excision circles.

Authors:  K Lima; T G Abrahamsen; I Foelling; S Natvig; L P Ryder; R W Olaussen
Journal:  Clin Exp Immunol       Date:  2010-05-10       Impact factor: 4.330

Review 3.  Tracking migration during human T cell development.

Authors:  Joanna Halkias; Heather J Melichar; Kayleigh T Taylor; Ellen A Robey
Journal:  Cell Mol Life Sci       Date:  2014-03-30       Impact factor: 9.261

4.  Rules of chemokine receptor association with T cell polarization in vivo.

Authors:  C H Kim; L Rott; E J Kunkel; M C Genovese; D P Andrew; L Wu; E C Butcher
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

5.  Glycoantigens induce human peripheral Tr1 cell differentiation with gut-homing specialization.

Authors:  Lori S C Kreisman; Brian A Cobb
Journal:  J Biol Chem       Date:  2011-01-12       Impact factor: 5.157

6.  Preferential Small Intestine Homing and Persistence of CD8 T Cells in Rhesus Macaques Achieved by Molecularly Engineered Expression of CCR9 and Reduced Ex Vivo Manipulation.

Authors:  Matthew T Trivett; James D Burke; Claire Deleage; Lori V Coren; Brenna J Hill; Sumiti Jain; Eugene V Barsov; Matthew W Breed; Joshua A Kramer; Gregory Q Del Prete; Jeffrey D Lifson; Adrienne E Swanstrom; David E Ott
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

7.  Abnormal regulation of chemokine TECK and its receptor CCR9 in the endometriotic milieu is involved in pathogenesis of endometriosis by way of enhancing invasiveness of endometrial stromal cells.

Authors:  Yun Wang; Jing Yu; Xuezhen Luo; Xiaoqiu Wang; Mingqing Li; Ling Wang; Dajin Li
Journal:  Cell Mol Immunol       Date:  2010-01       Impact factor: 11.530

8.  Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine.

Authors:  Farin F Amersi; Alicia M Terando; Yasufumi Goto; Richard A Scolyer; John F Thompson; Andy N Tran; Mark B Faries; Donald L Morton; Dave S B Hoon
Journal:  Clin Cancer Res       Date:  2008-02-01       Impact factor: 12.531

9.  A multipotent precursor in the thymus maps to the branching point of the T versus B lineage decision.

Authors:  Claudia Benz; Conrad C Bleul
Journal:  J Exp Med       Date:  2005-06-27       Impact factor: 14.307

10.  Tumor microenvironment immune-related lncRNA signature for patients with melanoma.

Authors:  Jia-Hui Guo; Shan-Shan Yin; Hua Liu; Feng Liu; Feng-Hou Gao
Journal:  Ann Transl Med       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.